Off-Label Use as a Standard of Care
- PMID: 33068530
- DOI: 10.1016/j.ajo.2020.09.014
Off-Label Use as a Standard of Care
Comment on
-
Cost-Utility Analysis of VEGF Inhibitors for Treating Neovascular Age-Related Macular Degeneration.Am J Ophthalmol. 2020 Oct;218:225-241. doi: 10.1016/j.ajo.2020.05.029. Epub 2020 Jun 19. Am J Ophthalmol. 2020. PMID: 32565050
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
